University of Virginia
Charlottesville, Virginia, 22908, United States
NCT Number: NCT01850069
The aim of this study is to determine whether we can predict the intracranial pressure using near infra-red spectroscopy
Looking for future studies?
Notify Me18 year–80 year
All sexes
Observational
Charlottesville, Virginia, 22908, United States
The management of intracranial hypertension requires the presence of an intracranial pressure monitor. We are investigating whether the waveforms obtained from a near infrared spectroscopy device can predict what the intracranial pressure is non-invasively.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Patients with an intracranial pressure monitor and arterial catheter who are admitted to the ICU
Exclusion criteria
Less than 18 years
Time frame: Participants will be followed while an arterial line and intracranial pressure monitor is present duing the ICU admission. This is expected to be an average of 5 days.
Intracranial elastance (δP/δV)will be measured by dividing the pulse pressure of an invasive arterial blood pressure by the amplitude of high frequency oscillations in the near infrared (NIR) absorbance waveforms.
University of Virginia
Other
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05593380
Brain Diseases, Brain Edema
Changde, Hunan, China
View Trial DetailsNCT06939114
Brain Diseases, Cardiovascular Diseases
Zurich, Canton of Zurich, Switzerland
View Trial DetailsNCT06571539
Brain Diseases, Central Nervous System Diseases
Jette, Belgium
View Trial DetailsNCT06367868
Brain Diseases, Central Nervous System Diseases
Istanbul, Fatıh, Turkey (Türkiye)
View Trial Details